CSIMarket
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QPRC's Operating Income Growth by Quarter and Year

Quest Patent Research's Operating Income results by quarter and year




QPRC Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.24 -0.33 -0.10
III Quarter September - -0.24 0.10 0.07
II Quarter June 0.11 0.75 -0.12 -0.36
I Quarter March -0.21 -0.24 -0.20 -0.29
FY   -0.10 0.03 -0.55 -0.68



QPRC Operating Income second quarter 2019 Y/Y Growth Comment
Quest Patent Research Corp reported drop in Operating Income in the second quarter by -85.88% to $ 0.11 millions, from the same quarter in 2018.
The fall in the second quarter Quest Patent Research Corp's Operating Income compares unfavorably to the Company's average Operating Income decline of -22.89%.

Looking into second quarter results within Biotechnology & Drugs industry 16 other companies have achieved higher Operating Income growth. While Quest Patent Research Corp' s Operating Income meltdown of -85.88% ranks overall at the positon no. 2348 in the second quarter.

Explain Operating Income growth


QPRC Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - 42.86 % -
II Quarter June -85.88 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Quest Patent Research's second quarter 2019 Operating Income $ 0.11 millions QPRC's Income Statement
Quest Patent Research's second quarter 2018 Operating Income $ 0.75 millions Quarterly QPRC's Income Statement
New: More QPRC's historic Operating Income Growth >>


QPRC Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #17
Healthcare Sector #158
Overall #2348

Operating Income Y/Y Growth Statistics
High Average Low
40.03 % -22.89 % -85.82 %
(Sep 30 2017)   (Jun 30 2019)
Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #17
Healthcare Sector #158
Overall #2348
Operating Income Y/Y Growth Statistics
High Average Low
40.03 % -22.89 % -85.82 %
(Sep 30 2017)   (Jun 30 2019)

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Quest Patent Research's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QPRC's II. Quarter Q/Q Operating Income Comment
II. Quarter 2019Periodic Quest Patent Research Corp in the influence Operating Loss of $ 0.11 millionsPeriodic influence appear to have added to Quest Patent Research Corp's return to positive trends, as QPRC deliverOperating Income of $ 0.11 millions in the II. Quarter 2019 emanate Operating Loss-0.21 millions in the first quarter. Quest Patent Research Corp announced in the II. Quarter 2019 Operating Income of $ 0.11 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Drugs industry Quest Patent Research Corp achieved highest sequential Operating Income growth. While Quest Patent Research's Operating Income growth quarter on quarter, overall rank is 0.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QPRC's II. Quarter Q/Q Operating Income Comment
II. Quarter 2019Cyclical Quest Patent Research Corp in the circumstances Operating Loss of $ 0.11 millionsCyclical circumstances appear to have led to Quest Patent Research Corp's return to recovery, as QPRC postOperating Income of $ 0.11 millions in the II. Quarter 2019 emanate Operating Loss-0.21 millions in the first quarter. Quest Patent Research Corp announced in the II. Quarter 2019 Operating Income of $ 0.11 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Drugs industry Quest Patent Research Corp achieved highest sequential Operating Income growth. While Quest Patent Research's Operating Income growth quarter on quarter, overall rank is 0.


Quest Patent Research's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Operating Income 12 Months Ending $ -0.58 $ 0.06 $ 0.03 $ -0.07 $ 0.27
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - 108.25 % - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Quest Patent Research Corp realized trailing twelve months Operating Loss of $ -1 millions, in the Jun 30 2019, compare to Operating Income of $ 0 millions a year ago.

Quest Patent Research Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Quest Patent Research Corp realized trailing twelve months Operating Loss of $ -1 millions, in the Jun 30 2019, compare to Operating Income of $ 0 millions a year ago.

Quest Patent Research Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
QPRC's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for QPRC's Competitors
Operating Income Growth for Quest Patent Research's Suppliers
Operating Income Growth for QPRC's Customers

You may also want to know
QPRC's Annual Growth Rates QPRC's Profitability Ratios QPRC's Asset Turnover Ratio QPRC's Dividend Growth
QPRC's Roe QPRC's Valuation Ratios QPRC's Financial Strength Ratios QPRC's Dividend Payout Ratio
QPRC's Roa QPRC's Inventory Turnover Ratio QPRC's Growth Rates QPRC's Dividend Comparisons



Companies with similar Operating Income meltdown for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2019
Prestige Consumer Healthcare Inc. -1.38 %$ -1.381 millions
Boston Scientific Corporation -2.04 %$ -2.041 millions
Neubase Therapeutics, Inc. -2.52 %$ -2.521 millions
Atrion Corp -2.66 %$ -2.663 millions
Tenax Therapeutics, Inc. -3.66 %$ -3.664 millions
Tenet Healthcare Corp -4.43 %$ -4.433 millions
Zynex Inc -4.83 %$ -4.825 millions
Orasure Technologies Inc -4.91 %$ -4.912 millions
Molecular Templates, Inc. -6.11 %$ -6.112 millions
Electromed, Inc. -6.62 %$ -6.621 millions
Baxter International Inc -7.55 %$ -7.552 millions
Integrated Biopharma Inc -8.00 %$ -8.000 millions
Stryker Corp -8.78 %$ -8.780 millions
Laboratory Corp Of America Holdings -9.07 %$ -9.074 millions
Hill-rom Holdings, Inc. -10.96 %$ -10.955 millions
Icu Medical Inc -12.44 %$ -12.438 millions
Inogen Inc -13.38 %$ -13.380 millions
Acadia Healthcare Company, Inc. -13.65 %$ -13.649 millions
Diffusion Pharmaceuticals Inc. -14.85 %$ -14.853 millions
National Healthcare Corp -16.24 %$ -16.243 millions
Merit Medical Systems Inc -19.27 %$ -19.274 millions
Pacira Biosciences, Inc. -19.35 %$ -19.355 millions
Henry Schein, Inc. -19.40 %$ -19.400 millions
Pacific Health Care Organization Inc -23.51 %$ -23.511 millions
Meridian Bioscience Inc -26.00 %$ -25.999 millions
Cambrex Corp -26.33 %$ -26.335 millions
Endo International Plc -27.93 %$ -27.928 millions
Biolife Solutions Inc -28.47 %$ -28.470 millions
Zimmer Biomet Holdings, Inc. -30.84 %$ -30.845 millions
Healthcare Services Group Inc -32.45 %$ -32.448 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HD's Profile

Stock Price

HD's Financials

Business Description

Fundamentals

Charts & Quotes

HD's News

Suppliers

HD's Competitors

Customers & Markets

Economic Indicators

HD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071